Search - tctmd.com

Displaying 301 - 320 of 395

Sort: Relevancy | Date

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Todd Neale

September 24, 2018

Polymer-Free BioFreedom Stent as Safe as Orsiro, but Not as Effective

News Conference News TCT 2018

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Michael O'Riordan

September 22, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

Michael O'Riordan

August 27, 2018

News Conference News ESC 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Michael O'Riordan

August 25, 2018

News Daily News

Multivitamin and Mineral Supplements Don’t Stave Off Heart Disease or Stroke: Meta-analysis

Caitlin E. Cox

July 13, 2018

News Daily News

IV Alteplase No Help for Minor, Nondisabling Strokes in PRISMS Trial

Todd Neale

July 11, 2018

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

News Daily News

Controversial Trial of Alcohol’s ‘Benefits’ for Preventing CVD Halted by NIH

Shelley Wood

June 19, 2018

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

News Daily News

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

L.A. McKeown

May 16, 2018

News Daily News

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

L.A. McKeown

May 15, 2018

News Conference News HRS 2018

NOACs Perform Worse Than Warfarin in Real-World Study, Especially When Adherence Is Low

Todd Neale

May 11, 2018

News Conference News EAS 2018

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Yael L. Maxwell

May 11, 2018

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

News Daily News

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Shelley Wood

March 29, 2018

News Daily News

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

Michael O'Riordan

February 21, 2018

News Daily News

Nonstatin Use and Expenditures Are Up Despite the Dearth of Evidence Supporting Efficacy

Yael L. Maxwell

January 29, 2018

Advertisement

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Multivitamin and Mineral Supplements Don’t Stave Off Heart Disease or Stroke: Meta-analysis

IV Alteplase No Help for Minor, Nondisabling Strokes in PRISMS Trial

New Review Probes Possibility of CVD Prevention Without Aspirin

Controversial Trial of Alcohol’s ‘Benefits’ for Preventing CVD Halted by NIH

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

NOACs Perform Worse Than Warfarin in Real-World Study, Especially When Adherence Is Low

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

Nonstatin Use and Expenditures Are Up Despite the Dearth of Evidence Supporting Efficacy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content